CY1111522T1 - 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο - Google Patents
84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινοInfo
- Publication number
- CY1111522T1 CY1111522T1 CY20111100538T CY111100538T CY1111522T1 CY 1111522 T1 CY1111522 T1 CY 1111522T1 CY 20111100538 T CY20111100538 T CY 20111100538T CY 111100538 T CY111100538 T CY 111100538T CY 1111522 T1 CY1111522 T1 CY 1111522T1
- Authority
- CY
- Cyprus
- Prior art keywords
- specific
- protein
- expressived
- protector
- cancer
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 230000001012 protector Effects 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 210000002307 prostate Anatomy 0.000 abstract 2
- 230000002381 testicular Effects 0.000 abstract 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 230000002611 ovarian Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17856000P | 2000-01-26 | 2000-01-26 | |
| EP08154530A EP1967586B1 (en) | 2000-01-26 | 2001-01-26 | 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111522T1 true CY1111522T1 (el) | 2015-08-05 |
Family
ID=22653018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100538T CY1111522T1 (el) | 2000-01-26 | 2011-06-03 | 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US7510855B2 (enExample) |
| EP (2) | EP1250434B1 (enExample) |
| JP (2) | JP3946044B2 (enExample) |
| AT (2) | ATE501255T1 (enExample) |
| AU (2) | AU3797301A (enExample) |
| CA (1) | CA2398064C (enExample) |
| CY (1) | CY1111522T1 (enExample) |
| DE (2) | DE60133627T2 (enExample) |
| DK (1) | DK1967586T3 (enExample) |
| ES (2) | ES2360155T3 (enExample) |
| IL (2) | IL150873A0 (enExample) |
| WO (1) | WO2001055391A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2360155T3 (es) | 2000-01-26 | 2011-06-01 | Agensys, Inc. | 84p2a9: una proteína específica de próstata y testículos altamente expresada en el cáncer de próstata. |
| US8168181B2 (en) * | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| CA2822302A1 (en) * | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Methods of impairing osteoclast differentiation |
| HK1210192A1 (en) | 2012-07-19 | 2016-04-15 | Alethia Biotherapeutics Inc. | Anti-siglec-15 antibodies |
| EP2892913A4 (en) * | 2012-09-07 | 2017-01-18 | Agency For Science, Technology And Research | Peptides and their uses |
| CN115836350A (zh) * | 2020-07-14 | 2023-03-21 | 米尼奥公司 | 用于确定新抗原的呈递可能性的方法、系统和计算机程序产品 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| PL196260B1 (pl) | 1997-02-25 | 2007-12-31 | Corixa Corp | Polipeptyd, cząsteczka DNA, komórka gospodarza, białko fuzyjne, kompozycje farmaceutyczne i szczepionki do leczenia raka prostaty |
| JP2001519666A (ja) | 1997-04-10 | 2001-10-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌発現配列タグ（ｓＥＳＴｓ） |
| JP2002519000A (ja) | 1998-01-28 | 2002-07-02 | カイロン コーポレイション | ヒト遺伝子および遺伝子発現産物ｉｉ |
| US6013450A (en) | 1998-02-20 | 2000-01-11 | Incyte Pharmaceuticals, Inc. | CAF1-related protein |
| CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1074617A3 (en) | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| AU2001229340A1 (en) | 2000-01-14 | 2001-07-24 | Millennium Pharmaceuticals, Inc. | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| ES2360155T3 (es) * | 2000-01-26 | 2011-06-01 | Agensys, Inc. | 84p2a9: una proteína específica de próstata y testículos altamente expresada en el cáncer de próstata. |
| WO2001055301A2 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US20030027139A1 (en) | 2000-04-06 | 2003-02-06 | Kenneth Jacobs | Polynucleotides encoding novel secreted proteins |
| CN1328147A (zh) | 2000-06-12 | 2001-12-26 | 上海博德基因开发有限公司 | 一种新的多肽——人磷脂酶49.06和编码这种多肽的多核苷酸 |
| US6974667B2 (en) | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
| IL154129A0 (en) | 2000-07-28 | 2003-07-31 | Compugen Inc | Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome |
| EP1346040A2 (en) | 2000-09-11 | 2003-09-24 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| WO2002031111A2 (en) | 2000-10-12 | 2002-04-18 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2002059271A2 (en) | 2001-01-25 | 2002-08-01 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
-
2001
- 2001-01-26 ES ES08154530T patent/ES2360155T3/es not_active Expired - Lifetime
- 2001-01-26 DE DE60133627T patent/DE60133627T2/de not_active Expired - Lifetime
- 2001-01-26 CA CA2398064A patent/CA2398064C/en not_active Expired - Fee Related
- 2001-01-26 ES ES01910358T patent/ES2304126T3/es not_active Expired - Lifetime
- 2001-01-26 WO PCT/US2001/002651 patent/WO2001055391A2/en not_active Ceased
- 2001-01-26 AT AT08154530T patent/ATE501255T1/de active
- 2001-01-26 US US09/771,312 patent/US7510855B2/en not_active Expired - Fee Related
- 2001-01-26 DK DK08154530.3T patent/DK1967586T3/da active
- 2001-01-26 AU AU3797301A patent/AU3797301A/xx active Pending
- 2001-01-26 AU AU2001237973A patent/AU2001237973B2/en not_active Ceased
- 2001-01-26 EP EP01910358A patent/EP1250434B1/en not_active Expired - Lifetime
- 2001-01-26 JP JP2001554420A patent/JP3946044B2/ja not_active Expired - Fee Related
- 2001-01-26 AT AT01910358T patent/ATE392474T1/de active
- 2001-01-26 EP EP08154530A patent/EP1967586B1/en not_active Expired - Lifetime
- 2001-01-26 DE DE60144204T patent/DE60144204D1/de not_active Expired - Lifetime
- 2001-01-26 IL IL15087301A patent/IL150873A0/xx unknown
-
2002
- 2002-07-23 IL IL150873A patent/IL150873A/en not_active IP Right Cessation
-
2006
- 2006-06-12 JP JP2006162937A patent/JP5501550B2/ja not_active Expired - Fee Related
- 2006-11-07 US US11/594,275 patent/US7582448B2/en not_active Expired - Fee Related
-
2008
- 2008-11-26 US US12/324,707 patent/US8013126B2/en not_active Expired - Fee Related
-
2011
- 2011-06-03 CY CY20111100538T patent/CY1111522T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL150873A0 (en) | 2003-02-12 |
| JP2006325595A (ja) | 2006-12-07 |
| ATE392474T1 (de) | 2008-05-15 |
| US20040126862A1 (en) | 2004-07-01 |
| DE60133627D1 (de) | 2008-05-29 |
| US8013126B2 (en) | 2011-09-06 |
| ES2304126T3 (es) | 2008-09-16 |
| JP5501550B2 (ja) | 2014-05-21 |
| AU2001237973B2 (en) | 2006-09-07 |
| EP1250434A2 (en) | 2002-10-23 |
| CA2398064C (en) | 2012-12-18 |
| WO2001055391A3 (en) | 2002-02-21 |
| US20090170191A1 (en) | 2009-07-02 |
| US7582448B2 (en) | 2009-09-01 |
| EP1967586A1 (en) | 2008-09-10 |
| US20070054363A1 (en) | 2007-03-08 |
| DE60144204D1 (de) | 2011-04-21 |
| JP2003520605A (ja) | 2003-07-08 |
| ES2360155T3 (es) | 2011-06-01 |
| IL150873A (en) | 2010-02-17 |
| EP1967586B1 (en) | 2011-03-09 |
| EP1250434B1 (en) | 2008-04-16 |
| AU3797301A (en) | 2001-08-07 |
| DK1967586T3 (da) | 2011-06-20 |
| DE60133627T2 (de) | 2009-07-30 |
| CA2398064A1 (en) | 2001-08-02 |
| US7510855B2 (en) | 2009-03-31 |
| ATE501255T1 (de) | 2011-03-15 |
| WO2001055391A2 (en) | 2001-08-02 |
| JP3946044B2 (ja) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111147T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
| HUP0203968A2 (hu) | Készítmények és eljárások prosztatarák terápiájára és diagnózisára | |
| CY1111522T1 (el) | 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο | |
| TR200102707T2 (tr) | AĞrì hafifletme, kemik kanseri terapisi ve kemik yzeyinin saĞlìklì tutulmasì iin kirelenmiç hedef dokulara ynelik radyum-223 hazìrlanmasì ve kullanìmì. | |
| PT1349870E (pt) | Composições para a terapêutica e diagnóstico do cancro do ovário | |
| DE60332355D1 (de) | Hla-a24-restringiertes krebsantigenpeptid | |
| EA200201258A1 (ru) | Способ лучевой терапии | |
| BG63122B1 (bg) | Съединения и методи за лечение на рак | |
| CY1108765T1 (el) | ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2 | |
| CY1116052T1 (el) | Θεραπευτικα και διαγνωστικα αντι-ηsρ70 αντισωματα | |
| DK0569527T3 (da) | Nedarvede og somatiske mutationer af APC-gen i colorektal cancer hos mennesker | |
| TR200001646T2 (tr) | Bir salgılanmış meme kanseri proteini olan mamaglobin. | |
| NO20071585L (no) | Ny anvendelse av peptidforbindelser for behandling av benkreftsmerte, kjemoterapi- og nucleosidfremkalt smerte | |
| BR0010702A (pt) | Novas quinonas como terapias de doenças | |
| CY1105818T1 (el) | Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου | |
| HUP0300054A1 (hu) | Daganatspecifikus állati fehérjék | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| AU3392901A (en) | Proteins | |
| CY1109029T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| AU2001233917A1 (en) | Bcmp-7 as marker for diagnosis of breast cancer | |
| CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
| AU6987696A (en) | The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells | |
| AU2002251754A1 (en) | Therapeutic modulation of the tumor inflammatory response | |
| ATE373711T1 (de) | Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten |